ADIMAB

Adimab's integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.

#People #Financial #Event #Website #More

ADIMAB

Social Links:

Facebook

Industry:

Biotechnology Collaboration Health Care Therapeutics

Founded:

2007-05-01

Address:

Lebanon, New Hampshire, United States

Country:

United States

Website Url:

http://www.adimab.com

Total Employee:

101+

Status:

Active

Contact:

(603) 643-7110

Email Addresses:

[email protected]

Total Funding:

45.48 M USD

Technology used in webpage:

IPv6 Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style 3 To 9 CcTLD Redirects Mapbox Materialize CSS ATT Perl

Current Advisors List

colin-greenspon_image

Colin Greenspon Advisor @ Adimab
Advisor

tillman-gerngross_image

Tillman Gerngross Board Member @ Adimab
Board_member

carl-l-gordon_image

Carl L. Gordon Board of Directors @ Adimab
Board_member

bill-maris_image

Bill Maris Member of the Board of Directors @ Adimab
Board_member

terrance-mcguire_image

Terrance McGuire Member of the Board of Directors @ Adimab
Board_member

Current Employees Featured

guy-van-meter_image

Guy Van Meter
Guy Van Meter VP, Head, Business Development @ Adimab
VP, Head, Business Development
2008-01-01

k-dane-wittrup_image

K. Dane Wittrup
K. Dane Wittrup Co-founder, Chair of the SAB @ Adimab
Co-founder, Chair of the SAB
2017-04-01

tillman-gerngross_image

Tillman Gerngross
Tillman Gerngross Founder & Executive Chairman @ Adimab
Founder & Executive Chairman

philip-chase_image

Philip Chase
Philip Chase CEO @ Adimab
CEO
2022-05-01

max-vasquez_image

Max Vasquez
Max Vasquez VP Computational Biology @ Adimab
VP Computational Biology
2007-06-01

eric-krauland_image

Eric Krauland
Eric Krauland President and Chief Scientific Officer @ Adimab
President and Chief Scientific Officer
2022-05-01

piotr-bobrowicz_image

Piotr Bobrowicz
Piotr Bobrowicz Director, Open Innovation @ Adimab
Director, Open Innovation
2008-01-01

errik-anderson_image

Errik Anderson
Errik Anderson Co-Founder @ Adimab
Co-Founder
2007-01-01

Founder

errik-anderson_image

Errik Anderson

k-dane-wittrup_image

K. Dane Wittrup

tillman-gerngross_image

Tillman Gerngross

Investors List

lux-capital_image

Investments List

Date	Company	Article	Money raised
2021-04-19	Adagio Therapeutics	Adimab investment in Series C - Adagio Therapeutics	336 M USD
2020-07-16	Adagio Therapeutics	Adimab investment in Series A - Adagio Therapeutics	50 M USD

Key Employee Changes

Date	New article
2022-05-09	Adimab Announces Promotions of New Chief Executive Officer and President

Official Site Inspections

http://www.adimab.com Semrush global rank: 4.56 M Semrush visits lastest month: 2.28 K

Host Informations
Whois Informations

Loading ...